CIK 0001347178 · Accelerated filer
Vanda Pharmaceuticals Inc.
Sign in to watch- Ticker
- VNDA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 030491827
- Phone
- 202-734-3400
- Business address
- 2200 PENNSYLVANIA AVE NW, SUITE 300E, WASHINGTON, DC, 20037
- 8-K Event Shareholder vote results
- DEFA14A Proxy Proxy Materials
- DEFA14A Proxy Proxy Materials
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 8-K Event Other events
- 8-A12B/A Other Registration Statement
- 8-K Event Material agreement · Shareholder rights changed
- ARS/A Other ARS/A
- ARS Other Annual Report to Security Holders
- DEF 14A Proxy Proxy Statement
- 8-A12B Other Registration of Securities
- 8-K Event Material agreement · Shareholder rights changed · Bylaws or fiscal year change · Other events
- 8-K Event Other events
- 8-K Event Other events
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
Page 8 of 67 · 1,337 filings